Загрузка...
Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma
Bromodomain and extraterminal (BET) domain containing protein (BRD)-4 modulates the expression of oncogenes such as c-myc, and is a promising therapeutic target in diverse cancer types. We performed pre-clinical studies in myeloma models with bi-functional protein-targeting chimeric molecules (PROTA...
Сохранить в:
| Опубликовано в: : | Leukemia |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6160356/ https://ncbi.nlm.nih.gov/pubmed/29581547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0044-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|